Skip to main content
Cancer Management and Research logoLink to Cancer Management and Research
. 2021 Sep 18;13:7245–7246. doi: 10.2147/CMAR.S339427

MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]

PMCID: PMC8457438  PMID: 34566431

Wang S, Du S, Lv Y, Zhang F, Wang W. Cancer Management and Research. 2019;11:3111–3123

The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 4D and 8B with similar images from unrelated articles, specifically:

The authors did not respond to our queries and the Editor determined the findings of the study were no longer valid and advised for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from Cancer Management and Research are provided here courtesy of Dove Press

RESOURCES